These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16622844)

  • 1. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C.
    Berenguer M; Palau A; Fernandez A; Benlloch S; Aguilera V; Prieto M; Rayón JM; Berenguer J
    Liver Transpl; 2006 Jul; 12(7):1067-76. PubMed ID: 16622844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
    Sharma P; Marrero JA; Fontana RJ; Greenson JK; Conjeevaram H; Su GL; Askari F; Sullivan P; Lok AS
    Liver Transpl; 2007 Aug; 13(8):1100-8. PubMed ID: 17377914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of acute rejection after interferon therapy in liver transplant recipients.
    Saab S; Kalmaz D; Gajjar NA; Hiatt J; Durazo F; Han S; Farmer DG; Ghobrial RM; Yersiz H; Goldstein LI; Lassman CR; Busuttil RW
    Liver Transpl; 2004 Jul; 10(7):859-67. PubMed ID: 15237369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I; Ulloa E; Colina F; Abradelo M; Jiménez C; Gimeno A; Meneu JC; Lumbreras C; Solís-Herruzo JA; Moreno E
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis.
    Berenguer M; Aguilera V; Prieto M; Ortiz C; Rodríguez M; Gentili F; Risalde B; Rubin A; Cañada R; Palau A; Rayón JM
    Liver Transpl; 2009 Jul; 15(7):738-46. PubMed ID: 19562707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience.
    Burra P; Targhetta S; Pevere S; Boninsegna S; Guido M; Canova D; Brolese A; Masier A; D'Aloiso C; Germani G; Tomat S; Fagiuoli S
    Transplant Proc; 2006 May; 38(4):1127-30. PubMed ID: 16757285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
    Cescon M; Grazi GL; Cucchetti A; Vetrone G; Ravaioli M; Ercolani G; Morelli MC; Piscaglia F; Tamè M; Pinna AD
    Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA; Terrault NA; Vardanian AJ; Bostrom A; Feng S
    Liver Transpl; 2004 Aug; 10(8):975-85. PubMed ID: 15390322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
    Arjal RR; Burton JR; Villamil F; Rosen HR
    Aliment Pharmacol Ther; 2007 Jul; 26(2):127-40. PubMed ID: 17593060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C.
    Burra P
    Semin Liver Dis; 2009 Feb; 29(1):53-65. PubMed ID: 19235659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C therapy before and after liver transplantation.
    Terrault NA
    Liver Transpl; 2008 Oct; 14 Suppl 2():S58-66. PubMed ID: 18825697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of HCV transplant patients with triple therapy.
    Coilly A; Roche B; Duclos-Vallée JC; Samuel D
    Liver Int; 2014 Feb; 34 Suppl 1():46-52. PubMed ID: 24373078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.
    Wang CS; Ko HH; Yoshida EM; Marra CA; Richardson K
    Am J Transplant; 2006 Jul; 6(7):1586-99. PubMed ID: 16827859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients.
    Tanaka T; Selzner N; Therapondos G; Renner EL; Lilly LB
    Transpl Int; 2013 Jan; 26(1):42-9. PubMed ID: 23137287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.